INDOMETHACIN CAPSULES

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the provision of INDOMETHACIN CAPSULES under NSN 6505009262154. The delivery order SPE2D226F3156 specifies a single shipment of one bottle at a unit price of $11.72, with delivery scheduled for August 3, 2026, to the USS ZUMWALT DDG 1000 at FPO AP 96693. The contract is structured as a delivery order issued under a broader government procurement vehicle with a ceiling value of $20,000,000, though only this one line item has been activated. Delivery is FOB destination, meaning the contractor bears all risk and cost until arrival at the government facility, and acceptance is performed by the government upon receipt. Invoicing must follow DFARS 252.232-7003 with Fast Pay Net 15 terms, and payments are processed through the Defense Finance and Accounting Service at P.O. Box 182317, Columbus, OH. The contract identifies the awardee as a Small Disadvantaged Women-Owned Business certified under the Women-Owned Small Business Program, triggering compliance obligations with SBA regulations and SAM reporting. Packaging and marking requirements mandate inclusion of contract identification numbers from Blocks 1 and 2 and the notation "SEE SCHEDULE" for certain government account packages, indicating detailed specifications reside in referenced but unprovided schedules. Administrative oversight is led by Contracting Officer Lisa Quinn and Local Administrator Jayne Do, both under DLA Troop Support. No statement of work, performance specifications, or detailed inspection standards are included in the available documentation, and while MIL-STD references are implied through MILSTRIP usage, no specific standards are stated. The contract type and evaluation factors remain unspecified, and no amendment or modification numbers are present, though the underlying contract is a solicitation-based instrument issued via RFP in 2024 with an effective date of March 7, 2025.